These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21695344)

  • 1. Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process.
    Cui D; Li Y; Lian M; Yang F; Meng Q
    Analyst; 2011 Aug; 136(15):3149-56. PubMed ID: 21695344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms.
    Krishnaiah Ch; Vishnu Murthy M; Kumar R; Mukkanti K
    J Pharm Biomed Anal; 2011 Mar; 54(4):667-73. PubMed ID: 21075576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a stability-indicating RP-HPLC method for the determination of fifteen impurities in rivaroxaban.
    Rao W; Li L; Zhang C; Zheng J; Fan X; Luan B; Sun J; Qiu M; Wu S; Li Y; Wang Z
    J Pharm Biomed Anal; 2023 May; 228():115325. PubMed ID: 36921446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Analysis and Quantitative Determination of Clevidipine Butyrate Impurities Using an Advanced RP-HPLC Method.
    Zhou Y; Zhou F; Yan F; Yang F; Yao Y; Zou Q
    J Chromatogr Sci; 2016 Mar; 54(3):353-60. PubMed ID: 26489435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography.
    Chandrashekara KA; Udupi A; Reddy CG
    J Chromatogr Sci; 2014 Sep; 52(8):799-805. PubMed ID: 23897663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of process related impurities of olanzapine using HPLC and ESI-MS/MS.
    Rao RN; Raju AN; Narsimha R; Babu GR
    J Sep Sci; 2008 Jan; 31(1):107-18. PubMed ID: 18080239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
    Reddy PS; Sudhakar Babu K; Kumar N
    J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a new stability indicating reversed phase liquid chromatographic method for the determination of prednisolone acetate and impurities in an ophthalmic suspension.
    Marley A; Stalcup AM; Connolly D
    J Pharm Biomed Anal; 2015 Jan; 102():261-6. PubMed ID: 25459922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Validated RP-HPLC Method for the Analysis of 1-Fluoronaphthalene and Its Process-Related Impurities.
    Karagiannidou EG; Bekiari ET; Vastardi EI
    J Chromatogr Sci; 2015 Sep; 53(8):1296-302. PubMed ID: 25713107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient.
    Thomas S; Bharti A; Tharpa K; Agarwal A
    J Pharm Biomed Anal; 2012 Feb; 60():86-90. PubMed ID: 22115882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
    J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability-indicating HPLC method for arteether and application to nanoparticles of arteether.
    Gugulothu D; Patravale V
    J Chromatogr Sci; 2014 Sep; 52(8):831-6. PubMed ID: 23983243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of process-related impurities including forced degradation products of alogliptin benzoate and the development of the corresponding reversed-phase high-performance liquid chromatography method.
    Zhou Y; Zhou W; Sun L; Zou Q; Wei P; OuYang P
    J Sep Sci; 2014 Jun; 37(11):1248-55. PubMed ID: 24616424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K; Kakde R; Sarma VU
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a stability-indicating RP-LC method for the separation of a critical pair of impurities and their degradants in zafirlukast.
    Thiyagarajan TK; Abdul Hakeem JA; Baksam V
    J Chromatogr Sci; 2012; 50(10):945-52. PubMed ID: 22689905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impurity profiling and a stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in halobetasol propionate 0.05% (w/w) cream.
    Prakash L; Malipeddi H; Subbaiah BV; Lakka NS
    J Chromatogr Sci; 2015 Jan; 53(1):112-21. PubMed ID: 24795078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.